Lacosamide drug class








Complete Lacosamide information from

01/29/2015
06:25 | Author: Molly Young

Epilepsy medicine pregnancy
Complete Lacosamide information from

Specific and up to date information about Lacosamide. Class: Anticonvulsant mainly as unchanged drug (40%), 30% as the O-desmethyl metabolite, and.

Do not freeze. Discard any unused oral solution remaining after 7 wk of first opening the bottle. Store between 59° and 86°F. Discard any unused portion of the injection. Following dilution, store IV form for up to 24 h at 59° to 86°F in glass or PVC bags.

Verify here. We comply with the HONcode standard for trustworthy health information.

Approximay 95% is eliminated in the urine and less than 0.5% in the feces, mainly as unchanged drug (40%), 30% as the O-desmethyl metabolite, and approximay 20% as a structurally unknown inactive polar metabolite.

Comments (1)Read more



VIMPAT (Lacosamide) dosage, indication, interactions, side effects

01/29/2015
04:10 | Author: Jeremy Rodriguez

Epilepsy medicine pregnancy
VIMPAT (Lacosamide) dosage, indication, interactions, side effects

VIMPAT (Lacosamide) drug information & product resources from MPR including Lacosamide 50mg, 100mg, 150mg, 200mg; tabs. Pharmacological Class:.

To enroll in the North American Antiepileptic Drug (NAAED) Pregnancy Registry call (888).

Monotherapy or as adjunct in partial-onset seizures.

Dizziness, diplopia, headache, nausea, vomiting, fatigue, ataxia; PR interval prolongation, AV block, syncope; rare: multiorgan hypersensitivity reaction (discontinue if occurs).

Company: UCB Inc. Generic Name and Formulations: Lacosamide 50mg, 100mg, 150mg, 200mg; tabs.

Select the drug indication to add to your list.

Cardiac conduction disturbances (eg, marked 1st or 2nd degree AV block, sick sinus syndrome unless paced, sodium channelopathies) or severe cardiac disease (eg, myocardial ischemia, HF, structural heart disease); obtain ECG before therapy and after titration.

Comments (2)Read more

Lacosamide - Medscape Reference

01/29/2015
02:35 | Author: Molly Young

Epilepsy medicine pregnancy
Lacosamide - Medscape Reference

Medscape - Indication-specific dosing for Vimpat (lacosamide), frequency-based adverse effects, Class: Anticonvulsants, Other In patients already taking an antiepileptic drug (AED), maintain lacosamide at recommended maintenance.

Comments (0)

Vimpat Drug Summary

01/29/2015
12:40 | Author: Jeremy Rodriguez

Epilepsy medicine pregnancy
Vimpat Drug Summary

PDR Drug Summaries are concise point-of-care prescribing, dosing and (lacosamide) - Kremers Urban Pharmaceuticals Inc. THERAPEUTIC CLASS.

Titrate: Increase by 50mg bid at weekly intervals. Consider dosage supplementation of up to 50% following a 4-hr hemodialysis treatment. Refer to PI if switching from PO to IV dosing or vice versa. Alternative: LD: 200mg. Discontinuation: Gradually withdraw over at least 1 week. Adjunctive Therapy: Initial: 50mg bid. Alternative: LD: 200mg. Pediatrics: ≥17 Yrs: Monotherapy: Initial: 100mg bid. Follow 12 hrs later by 100mg bid for 1 week. Maint: 100-200mg bid. Concomitant Strong CYP3A4 and CYP2C9 Inhibitors with Renal/Hepatic Impairment: Dose reduction may be necessary.

Comments (4)Read more

New epilepsy drug called Vimpat (lacosamide)Drug Class

01/29/2015
02:35 | Author: Molly Young

Epilepsy medicine pregnancy
New epilepsy drug called Vimpat (lacosamide)Drug Class

What is Vimpat (lacosamide) and when will it be used? How does it compare to other antiepileptics? Does it cause any major drug interactions or cardiac effects.

Comments (0)